Live Breaking News & Updates on Gilmore Neil Oneill|Page 5
Stay updated with breaking news from Gilmore neil oneill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Analysts at Cantor Fitzgerald upped their FY2023 earnings estimates for Editas Medicine in a report issued on Tuesday, August 8th. Cantor Fitzgerald analyst R. Bienkowski now forecasts that the company will post earnings per share of ($2.35) for the year, up from their prior estimate of ($2.43). […] ....
Oppenheimer restated their market perform rating on shares of Editas Medicine (NASDAQ:EDIT – Free Report) in a research report report published on Thursday morning, Benzinga reports. They currently have a $12.00 price target on the stock. EDIT has been the subject of a number of other research reports. StockNews.com lowered Editas Medicine from a hold […] ....
Editas Medicine (NASDAQ:EDIT – Free Report) had its price objective cut by Chardan Capital from $22.00 to $19.00 in a report published on Wednesday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock. EDIT has been the topic of a number of other reports. Raymond James upgraded shares of Editas Medicine […] ....
Editas Medicine (NASDAQ:EDIT – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.76) by $0.20, Briefing.com reports. The business had revenue of $2.89 million during the quarter, compared to analysts’ expectations of $4.17 million. Editas Medicine had […] ....
Editas Medicine (NASDAQ:EDIT – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.76) by $0.20, Briefing.com reports. The firm had revenue of $2.89 million for the quarter, compared to the consensus estimate of $4.17 million. Editas Medicine had a negative net […] ....